Skip to content
§00 // NYSE · HEALTHCARE

Merck & Co. Inc. (MRK)

// research · charts · filings · insider activity

[ $152.34 ] +0.70 (+0.46%) · MKT_CAP $376B · VOL 576
// last_quote · 2026-09-04 10:19:55 UTC

Merck's Keytruda is the best-selling oncology drug in the world. The company is racing to build a post-Keytruda pipeline before the patent cliff in the late 2020s.

[ + ADD MRK TO WATCHLIST — FREE 7-DAY PRO, NO CARD ]
{/* P3-7 C7: pass a sentence-case label directly so the symbol stays uppercase (the brutalistCTA label-transformer lowercases any all-upper-snake arg, hence the legacy 'Open aapl research'). Sentence-case input bypasses the transform. */} Open MRK research View pricing
§01 // WHAT_TAPEBOARD_SHOWS_FOR_MRK
§02 // HOW_TO_RESEARCH_MRK
  1. start with the overview, open the scanner, click MRK, or search the top bar. unified page: price, profile, latest headlines.
  2. scan filings next, 8-k feed surfaces material events (earnings, m&a, insider changes). ai summary ships the takeaway in one paragraph.
  3. check insider activity, a cluster of form 4 buys from executives often precedes outperformance. feed groups by signer.
  4. size in the simulator, paper-trade MRK with l2-walked fills before risking capital. analytics tracks win rate, profit factor, expectancy.
§03 // RELATED_TICKERS

// traders watching MRK often track:

[ PFE ][ BMY ][ ABBV ]
§04 // SCAN_THE_WHOLE_MARKET

// Find more setups like MRK across the tape:

// PENNY_STOCK_SCANNER// UNUSUAL_VOLUME_SCANNER// TOP_GAINERS_TODAY// PREMARKET_MOVERS// ALL_MARKET_MOVERS
§05 // OPEN_TERMINAL

See MRK on a real terminal.

// 28 sec to first quote · no card · cancel anytime

[ + ADD MRK TO WATCHLIST — FREE 7-DAY PRO, NO CARD ]
View pricing